EUVIMEDEUVIMED entdecken
Vergleichsstudie

Use of preoperative erythropoietin‐stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia

Una E Choi iD, Ryan C Nicholson, Steven M Frank iD, Stephanie Cha, Brian C Cho, Jennifer S Lawton, Laeben C Lester, Nadia B Hensley iD

Vox Sanguinis · 2024

DOI: 10.1111/vox.13729 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Vox Sanguinis, 2024. Verfasst von Una E Choi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Erythrocyte Transfusion, Anemia, Hematinics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Preoperative red blood cell (RBC) transfusions increase post‐operative venous thromboembolic (VTE) events. Erythropoietin‐stimulating agents (ESAs) increase VTE risk in cancer patients; we aimed to assess ESA versus RBC‐associated VTE risks in a broad population of surgical patients. Materials and Methods We queried TriNetX Diamond Network from 2006 to 2023, comparing patients with anaemia within 3 months preoperatively who received preoperative ESAs with or without intravenous (IV) iron to patients who received preoperative RBCs. Sub‐analyses included (1) all surgeries and (2) cardiovascular surgeries. We propensity score matched for demographics, comorbidities, medical services, post‐treatment haemoglobin (g/dL) and, for all‐surgery comparisons, surgery type. Outcomes included 30‐day post‐operative mortality, VTE, pulmonary embolism (PE), disseminated intravascular coagulation (DIC) and haemoglobin.

Results

In our 19,548‐patient cohorts, compared with preoperative RBC transfusion, ESAs without IV iron were associated with lower mortality (relative risk [RR] = 0.51 [95% confidence interval (CI), 0.45–0.59]), VTE (RR = 0.57 [0.50–0.65]) and PE (RR = 0.67 [0.54–0.84]). Post‐operative haemoglobin was higher in the ESA without IV iron cohort compared with the transfusion cohort (10.0 ± 1.4 vs. 9.4 ± 1.8 g/dL, p = 0.002). Cardiac surgical patients receiving ESAs with or without IV iron had lower risk for post‐operative mortality, VTE and PE ( p < 0.001) than those receiving RBCs. Post‐operative haemoglobin differed between patients receiving ESAs with IV iron versus RBCs (10.1 ± 1.5 vs. 9.4 ± 1.9 g/dL, p = 0.0009).

Conclusion

Compared with surgical patients who were transfused RBCs, ESA recipients had reduced 30‐day post‐operative risk of mortality, VTE, PE and DIC and increased haemoglobin levels. IV iron given with ESAs improved mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erythrocyte TransfusionAnemiaHematinicsHumansMaleFemaleMiddle AgedAgedPostoperative ComplicationsPreoperative CareVenous ThromboembolismErythropoietinThrombosis

Stichwörter der Autor:innen

blood transfusioncardiac surgeryperioperative transfusionplasmathromboembolism

Substanzen

HematinicsErythropoietin

Autor:innen und Institutionen

  • Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Cardiac Surgery Division, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Una E Choi, Steven M Frank, Nadia B Hensley

Zitieren

APA

Choi, U. E., Nicholson, R. C., Frank, S. M., Cha, S., Cho, B. C., Lawton, J. S., Lester, L. C., & Hensley, N. B. (2024). Use of preoperative erythropoietin‐stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia. Vox Sanguinis. https://doi.org/10.1111/vox.13729

Vancouver

Choi UE, Nicholson RC, Frank SM, Cha S, Cho BC, Lawton JS, et al. Use of preoperative erythropoietin‐stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia. Vox Sanguinis. 2024. doi:10.1111/vox.13729

BibTeX
@article{Choi2024,
  author = {Choi, Una E and Nicholson, Ryan C and Frank, Steven M and Cha, Stephanie and Cho, Brian C and Lawton, Jennifer S and Lester, Laeben C and Hensley, Nadia B},
  title = {Use of preoperative erythropoietin‐stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia},
  journal = {Vox Sanguinis},
  year = {2024},
  doi = {10.1111/vox.13729}
}
Kostenlos starten →